Indications
The medication is used for the prevention and treatment of hepatic encephalopathy and constipation.
Effect
Lactulose-MIP 9.75 g/15 ml syrup is a disaccharide composed of D-galactose and fructose. It is a mild laxative with an osmotic effect. Two phenomena are responsible for the laxative effect of lactulose: sugars and acids cause a change in osmotic pressure (increase in the volume of intestinal contents), which indirectly stimulates intestinal peristalsis, while acids directly stimulate intestinal peristalsis.
Lactulose-MIP also helps to lower blood ammonia levels.
Dosage
Oral, individual.
Constipation: Adults: 10-15 ml 1-2 times daily.
Hepatic encephalopathy: Adults: initially 10-15 ml 3 times daily, then 30-45 ml 3-4 times daily.
The dosage should be adjusted so that the patient has soft stools 2-3 times daily.
Children – no data available.
The preparation can be administered after dilution with water or other liquids, regardless of meals.
Contraindications
Hypersensitivity to the ingredients of the preparation. Intestinal obstruction. Inflammation of the digestive tract. Disturbances of water-electrolyte balance. Hereditary fructose intolerance. Disorders of lactase production. Galactosemia. Disorders of intestinal absorption of glucose and galactose.
Ingredients
15 ml syrup contains 9.75 g lactulose.
